Enterococcus Faecalis, Pneumococcinum, Streptococcus Agalactiae, Streptococcus Agalactiae Dna, Streptococcus Bovis, Streptococcus Dysgalactiae, Streptococcus Dysgalactiae Dna, Streptococcus Mutans, Streptococcus Mutans Dna, Streptococcus Oralis, Streptococcus Pneumoniae, Streptococcus Pneumoniae Dna, Streptococcus Uberis, Streptococcus Viridans Liquid
NDC 43742-2272
View dosage, usage, ingredients, routes, and UNII mappings.
Product Information
This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.
Enterococcus Faecalis, Pneumococcinum, Streptococcus Agalactiae, Streptococcus Agalactiae Dna, Streptococcus Bovis, Streptococcus Dysgalactiae, Streptococcus Dysgalactiae Dna, Streptococcus Mutans, Streptococcus Mutans Dna, Streptococcus Oralis, Streptococcus Pneumoniae, Streptococcus Pneumoniae Dna, Streptococcus Uberis, Streptococcus Viridans is a DRUG FOR FURTHER PROCESSING-approved product labeled by Deseret Biologicals. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a liquid. This product entry covers the primary NDC 43742-2272 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
NDC Product Code:
43742-2272
Proprietary Name:
Enterococcus Faecalis, Pneumococcinum, Streptococcus Agalactiae, Streptococcus Agalactiae Dna, Streptococcus Bovis, Streptococcus Dysgalactiae, Streptococcus Dysgalactiae Dna, Streptococcus Mutans, Streptococcus Mutans Dna, Streptococcus Oralis, Streptococcus Pneumoniae, Streptococcus Pneumoniae Dna, Streptococcus Uberis, Streptococcus Viridans
Non-Proprietary Name: [1]
Enterococcus Faecalis, Pneumococcinum, Streptococcus Agalactiae, Streptococcus Agalactiae Dna, Streptococcus Bovis, Streptococcus Dysgalactiae, Streptococcus Dysgalactiae Dna, Streptococcus Mutans, Streptococcus Mutans Dna, Streptococcus Oralis, Streptococcus Pneumoniae, Streptococcus Pneumoniae Dna, Streptococcus Uberis, Streptococcus Viridans
Substance Name: [2]
Enterococcus Faecalis; Herring Sperm Dna; Streptococcus Agalactiae; Streptococcus Dysgalactiae; Streptococcus Equinus; Streptococcus Mutans; Streptococcus Oralis; Streptococcus Pneumoniae; Streptococcus Uberis; Streptococcus Viridans Group
NDC Directory Status:
Drug For Further Processing
Product Type: [3]
UNFINISHED PRODUCT INCLUDED in the NDC Directory
Code Navigator:
Clinical Specifications
Dosage Form:
Liquid
- A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Labeler & Regulatory Data
Labeler Name: [5]
Labeler Code:
43742
Marketing Category: [8]
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Marketing Timeline
Start Marketing Date: [9]
05-06-2025
Listing Expiration Date: [11]
12-31-2026
Exclude Flag: [12]
N
Unfinished Product: [13]
Yes
Code Structure Chart
Product Details
What is NDC 43742-2272?
The NDC code 43742-2272 is assigned by the FDA to the product Enterococcus Faecalis, Pneumococcinum, Streptococcus Agalactiae, Streptococcus Agalactiae Dna, Streptococcus Bovis, Streptococcus Dysgalactiae, Streptococcus Dysgalactiae Dna, Streptococcus Mutans, Streptococcus Mutans Dna, Streptococcus Oralis, Streptococcus Pneumoniae, Streptococcus Pneumoniae Dna, Streptococcus Uberis, Streptococcus Viridans. It is commonly known by its generic name, enterococcus faecalis, pneumococcinum, streptococcus agalactiae, streptococcus agalactiae dna, streptococcus bovis, streptococcus dysgalactiae, streptococcus dysgalactiae dna, streptococcus mutans, streptococcus mutans dna, streptococcus oralis, streptococcus pneumoniae, streptococcus pneumoniae dna, streptococcus uberis, streptococcus viridans. This pharmaceutical product is labeled by Deseret Biologicals and is currently categorized as listed product. The medication is a liquid. In terms of distribution, this product is available in a single package configuration. The associated package NDC(s) include: 43742-2272-1. Beyond standard identification, this entry provides technical data including pharmacologic classes, UNII ingredient references, and RxNorm cross-referencing for healthcare systems.
What are Active Ingredients of this product?
An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
- ENTEROCOCCUS FAECALIS 200 [hp_X]/mL - A species of gram-positive, coccoid bacteria commonly isolated from clinical specimens and the human intestinal tract. Most strains are nonhemolytic.
- HERRING SPERM DNA 200 [hp_X]/mL
- STREPTOCOCCUS AGALACTIAE 200 [hp_X]/mL - A bacterium which causes mastitis in cattle and occasionally in man.
- STREPTOCOCCUS DYSGALACTIAE 200 [hp_X]/mL
- STREPTOCOCCUS EQUINUS 200 [hp_X]/mL - A species of gram-positive, coccoid bacteria commonly found in the alimentary tract of cows, sheep, and other ruminants. It occasionally is encountered in cases of human endocarditis. This species is nonhemolytic.
- STREPTOCOCCUS MUTANS 200 [hp_X]/mL - A polysaccharide-producing species of STREPTOCOCCUS isolated from human dental plaque.
- STREPTOCOCCUS ORALIS 200 [hp_X]/mL - A species of gram-positive, coccoid bacteria that is numerous in the mouth and throat. It is a common cause of endocarditis and is also implicated in dental plaque formation.
- STREPTOCOCCUS PNEUMONIAE 200 [hp_X]/mL - A gram-positive organism found in the upper respiratory tract, inflammatory exudates, and various body fluids of normal and/or diseased humans and, rarely, domestic animals.
- STREPTOCOCCUS UBERIS 200 [hp_X]/mL
- STREPTOCOCCUS VIRIDANS GROUP 200 [hp_X]/mL
* Please review the full disclaimer at the bottom of this page.
Product & Regulatory Definitions
What is the Non-Proprietary Name? The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
What is the Substance Name? An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
What kind of product is this? Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
What is the Labeler Name? Name of Company corresponding to the labeler code segment of the Product NDC.
What is the Marketing Category? Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
What is the Start Marketing Date? This is the date that the labeler indicates was the start of its marketing of the drug product.
What is the Listing Expiration Date? This is the date when the listing record will expire if not updated or certified by the product labeler.
What is the NDC Exclude Flag? This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions, or because the listing certification is expired, or because the listing data was inactivated by FDA, or because it was discontinued by the labeler. Possible values in this field are: "D", "E", "I", "N", "U".
What is an Unfinished Product? This field indicates if the product is an unfinished drug. An unfinished drug is an active pharmaceutical ingredient either alone or with other ingredients that is not a finished drug product. Unfinished drugs are used to process other drugs or for drug compounding.
